Professor of Targeted Therapy and Oncology
0161 446 8574
0161 446 3265
BSc PhD MB BS DRCOG MRCP FRCR FRCPath
Deputy Director, Institute of Cancer Sciences
Head of Division of Cancer Sciences
After completing his undergraduate degree in Biochemistry (BSc) at London University, Dr Illidge received his medical degree (MB BS) from Guy's Hospital Medical School, London, and subsequently was awarded a PhD from the University of Southampton for his work in the field of lymphoma. Dr Illidge completed research fellowships as Cancer Research UK (CRUK) Senior Clinical Research Fellow and was appointed Senior Lecturer and Honorary Consultant in Oncology at Southampton University Hospitals NHS Trust in 1999. He was a awarded a US Senior Fulbright fellowship and a Winston Churchill Fellowship which enabled him to work as part of the lymphoma team at Stanford University, California, in 1998. He is a Member of the Royal College of Physicians, Fellow of the Royal College of Radiologists and Fellow of the Royal College of Pathologists.
Dr Illidge moved his CRUK research group to the Cancer Research UK Manchester Institute (then known as the Paterson Institute) and The Christie in 2004, and his research is based on developing new antibody-based therapies for lymphoma. His clinical interest is in lymphoma where he has led many early phase and late clinical trials and is recognised as an international expert in antibodies and radioimmunotherapy applied to lymphoma, and he has published extensively (more than 100 publications). He serves on the central steering group of the National Cancer Research Institute lymphoma group, has represented the UK at international workshops in lymphoma and is a member of the American Society of Hematologists. He was awarded the Institute of Cancer Sciences researcher of the year in 2012 and the University of Manchester Faculty of Medicine and Life Science researcher of the year in 2013